Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

Health Catalyst Acquires Medicity, Extending Its Leadership as the Data Platform for Healthcare

SALT LAKE CITY, July 11, 2018 – Health Catalyst, a leader in next-generation data, analytics,  and decision support, today announced completion of its acquisition of Medicity, one of the nation’s largest population health management companies with solutions for health information exchange (HIE), business intelligence, and provider and patient engagement.

Medicity adds to the Health Catalyst customer base more than 100 clients including 21 state and regional HIEs, large employers, health plans, 75 health systems encompassing over 1,000 hospitals and more than 185,000 providers in physician groups and extended care facilities, in support of over 75 million patients. The combined company is positioned to solve many of the most pressing problems of large healthcare delivery networks as they seek to improve the quality and lower the cost of patient care across communities.

“The future of healthcare will rely on the broad and more effective use of data to improve quality and costs, and with this acquisition, Health Catalyst can combine its expertise in data, analytics and decision support, including a data asset of over 100 million patients, with the expertise of Medicity in data exchange across the continuum of care,” said Dan Burton, CEO of Health Catalyst. “Medicity’s experienced team, extensive client roster, expansive data sets, and significant transactional capabilities are a compelling complement to Health Catalyst’s team, capabilities and offerings. Together, we’re well positioned to scale and to offer solutions designed to help our clients apply data-driven insights in a value-based care environment.”

The acquisition combines Medicity’s deep clinical dataset of over 75 million patients and significant transactional capabilities with Health Catalyst’s Data Operating System (DOS™) including AI-driven analytics and business intelligence, and a broad set of financial, cost, patient outcomes, and supply chain data from over 400 hospitals, 4,000 clinics and a data set of over 100 million patients nationwide. The unique combination will empower connected communities with the insights required to improve healthcare outcomes, control costs, and advance population health management.

“The combination of Medicity with Health Catalyst represents the best of both worlds – the transactional capabilities that our customers have been asking for, along with the analytics that Medicity’s customers have sought, delivered now from one company,” said Health Catalyst President Brent Dover, who was president of Medicity before joining Health Catalyst in 2013. “We share complementary technologies, a home base in Salt Lake City, a culture of innovation, and a commitment to improving healthcare. We believe customers of both companies will benefit.”

The integration of Medicity significantly expands the capabilities of the Health Catalyst Data Operating System, which will now have the unique ability to receive and analyze data in real time, and then embed the resulting insights into the workflow of virtually every Electronic Health Record (EHR) on the market today. The combined companies will also have a compelling solution for, and expertise in, the loosely affiliated community ambulatory care management space. These organizations, primarily independent physician groups, are in dire need of a simple means of integrating data between EHRs at the patient encounter level, with enough clinical quality analytics to meet the legal requirements of a Clinically Integrated Network.

“Adding Medicity’s data skills and technology, particularly in physician-led value-based care networks, is a great complement to our solutions,” said Dale Sanders, Health Catalyst’s president of technology. “Both customer bases will benefit from this acquisition. Medicity is very skilled at delivering a high volume of data exchange transactions with high availability. Health Catalyst excels at the bulk movement, curation, and analysis of data, while Medicity has complementary data content that will enhance the precision of our AI algorithms. They have great technology for interacting with literally every EHR under the sun, which will enhance our ability to embed analytics and decision support at the point of care, regardless of who the EHR vendor is.”

Sanders added, “I’ve always been intrigued by the analytics of HIE data traffic; not the data content but rather the network analysis of message types, destinations, and the timing of those messages. We plan on combining that metadata analysis with our data content analysis for new insights into population health, referral patterns, and patient outcomes in a region.  For the promise it offers, I believe this is a good acquisition for the industry.”

About Health Catalyst

Health Catalyst is a next-generation data, analytics, and decision-support company, committed to being a catalyst for massive, sustained improvements in healthcare outcomes. We are the leaders in a new era of advanced predictive analytics for population health and value-based care with a suite of machine learning-driven solutions, decades of outcomes improvement expertise, and an unparalleled ability to unleash and integrate data from across the healthcare ecosystem. Our Health Catalyst Data Operating System (DOS™)—a next-generation data warehouse and application development platform powered by data from more than 100 million patients, and encompassing over 1 trillion facts—helps improve quality, add efficiency and lower costs for organizations ranging from the largest US health system to forward-thinking physician practices. Our technology and professional services can help you keep patients engaged and healthy in their homes, communities, and workplaces, and we can help you optimize care delivery to those patients when it becomes necessary. We are grateful to be recognized by Fortune, Gallup, Glassdoor, Modern Healthcare and a host of others as a Best Place to Work in technology and healthcare. Visit www.healthcatalyst.com, and follow us on TwitterLinkedIn and Facebook. 

July 11, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Hg Invests in Orion Health Rhapsody and Population Health Businesses

BOSTON, Massachusetts – 6 July 2018 – Orion Health Group Limited (NZX:OHE/ASX:OHE) announced that it has reached an agreement in relation to Orion Health’s Rhapsody and Population Health businesses with Hg, a specialist technology investor committed to helping build global businesses with funds of c.£10 billion under management.

The agreement is for entities managed by Hg to acquire majority ownership of Orion Health’s Rhapsody business and to invest in Orion Health’s Population Health business.

Healthcare technology is a core investment area for Hg, having recently completed a number of transactions across the sector. This investment will be made from Hg’s Mercury 2 Fund.

Orion Health built the first Rhapsody integration engine in the late-1990s quickly becoming one of the most recognized interoperability platforms for healthcare organizations today. The combination of Rhapsody’s global team and Hg’s resources will extend Rhapsody as a leader in the interoperability platform space, building on both Rhapsody’s world class technology and highly rated customer service.

Philippe Houssiau, an experienced global technology executive, will step in to lead the Rhapsody business. Philippe has broad experience in leading healthcare businesses, consulting and start-ups, and is formerly CEO of Agfa Healthcare, CEO of Alliance Medical and a Senior Partner with PwC.

“This investment provides Orion Health with a tremendous opportunity to deliver on our vision for customers, our people and for the healthcare sector,” said Ian McCrae, Founder and CEO, Orion Health. “The Board and I believe that Hg is the right partner to accelerate the expansion of Rhapsody and support our vision for our Population Health business.”

“Hg has been researching the theme of interoperability and population health management in healthcare IT over many years,” said David Issott, Partner, Hg. “We believe this is a key global growth theme backed by substantial market funding and resources. Rhapsody provides fantastic products and services for this market and we look forward to partnering with the team at Rhapsody to maximize its potential across the globe. We are also excited to work with Ian and the team to realize the full potential of the Population Health business.”

“Rhapsody is a high-quality business with strong underlying fundamentals and a solid pipeline of new business,” said Philippe Houssiau, CEO Rhapsody. “We believe that the current healthcare market dynamic, with increasing requirement for ‘data liquidity’, presents Rhapsody with a real opportunity for further growth and a solid base for sustained performance. With a focused leadership team and the investment provided by Hg, Rhapsody will be able to leverage its core markets whilst expanding into selected and emerging segments.”

Full details of the transaction can be found in a Market Release on the investor page of Orion Health’s website here. Summary:

–          Hg will acquire Rhapsody for NZ$205 million funded by debt and equity arranged by Hg. Orion Health will then utilize circa NZ$28 million of the transaction proceeds to acquire an ongoing 24.9% shareholding in the Rhapsody business.

–          Hg will also acquire a 24.9% stake in Population Health by investing circa NZ$20 million in that business. Orion Health will invest around NZ$12 million of the Rhapsody transaction proceeds in Population Health based on an agreed enterprise value of NZ$50 million (on a cash free and debt free basis) together with NZ$30 million of net cash to fund ongoing operations.

–          Orion Health will continue to own 100% of its Hospitals business.

–          Following completion of the Hg Transaction, Orion Health will undertake a share buyback offer at an estimated price range of $1.24-$1.29 per share, with the final offer price dependent on Orion Health’s available cash immediately following completion taking into account transaction costs and working capital adjustments in relation to the Rhapsody transaction. Shareholders will have the option to accept the share buyback offer in respect of all or a specified proportion of their Orion Health shares.

–          The bottom of the estimated buy back price range represents a premium of 46% to the closing price per Orion Health share of $0.85 on 2 July 2018 and 55% to the volume weighted average trading price over the last 20 trading days.

The injection of capital will provide investment for Orion Health to build leading global technology for the healthcare sector.

“As the healthcare sector evolves, so too has Orion Health. We believe the biggest advances in healthcare technology will come from a range of capabilities including advanced analytics and better data flow to address critical issues within the sector. In the face of growing and aging populations and the rise of chronic diseases, health systems the world over are under enormous strain. Our Population Health and Hospitals solutions are focused on helping healthcare organizations turn data into insights and clinical action and allow them to use this knowledge to optimize budgets and provide targeted patient care.

“This injection of capital will advance Orion Health’s businesses to reach their full potential over time. For our Population Health business, it will help strengthen our position as a market leader, and for our Hospitals business, it will further support its growth,” said McCrae.

The transaction is subject to a number of conditions, including regulatory approval and the share buyback offer by Orion Health’s shareholders. A notice of meeting describing the Hg Transaction and the share buyback offer will be circulated to shareholders. The independent directors have also commissioned an independent report from KordaMentha.

“This transaction is an important stepping stone in Orion Health’s efforts to build a solid and competitive business and provides our shareholders with choice in relation to their investment,” said Andrew Ferrier, Chairman of the Board, Orion Health. “We believe that providing shareholders both the option to cash-out at a substantial premium to the current trading price and the opportunity to elect to maintain an ongoing investment in Orion Health, including its 24.9% stake in Rhapsody and 75.1% stake in Population Health, is in the best interests of shareholders. This transaction has strong support from Orion Health’s Board and major shareholders.”

About Orion Health
Orion Health (NZX:OHE/ASX:OHE) is a health technology company that provides solutions which enable healthcare to over 110 million patients globally. Its open technology platform, Orion Health Amadeus, seamlessly integrates all forms of relevant data to enable population and personalized healthcare around the world. The company is committed to continual innovation to cement its position at the forefront of precision medicine. For more information visit www.orionhealth.com.

About Hg
Hg is a sector expert investor, committed to helping build ambitious businesses across the technology, services and industrial technology space, primarily in Europe. Deeply resourced sector teams focus on specific sub-sectors and investment themes to identify companies occupying an established position within a niche, and which have the potential to grow faster than their market, create employment and become the leader in their industry. Hg’s dedicated operations innovation team provides practical support to management teams to help them realise their growth ambitions. Based in London and Munich, Hg has funds under management of c. £10 billion serving some of the world’s leading institutional and private investors. For further details, please see www.hgcapital.com

July 9, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Inspirata Acquires Health Analytics Company, Caradigm; Plans to Use its Award-Winning Platform to Accelerate Development of its Cancer Information Data Trust

Inspirata will continue to evolve Caradigm’s population health management solutions and support existing customers, and has aggressive plans to create new customers in this space.

Redmond, WA, June 13, 2018 (GLOBE NEWSWIRE) — Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has acquired Redmond, WA-based Caradigm from GE Healthcare.

The company’s award-winning Caradigm Intelligence Platform (CIP) and population health management software portfolio spans data control; healthcare analytics; and care coordination and engagement across the entire healthcare enterprise, including large integrated delivery networks, accountable care organizations, clinically integrated networks, academic medical centers and community hospital networks.

“Caradigm has built a highly regarded, industry-proven big data health analytics platform,” says Inspirata CEO Satish Sanan. “Our goal is to leverage the core strengths of this platform to accelerate our Cancer Information Data Trust (CIDT) development. The CIDT will address key trends in oncology care providing important new insights for clinicians, researchers, drug discovery and cancer center operations. In addition to this, Caradigm’s strong population health product set and experienced team will have Inspirata’s specialized focus and attention to promote long-term sustainability, growth and innovation as we redouble our focus on delivering superior value to all customers.”

“We are confident that Inspirata will be able to provide the intense focus and vision needed for growth through key investments in technology, infrastructure and people to energize the Caradigm software portfolio to better enable us to serve customers’ evolving needs,” says Caradigm President and CEO Neal Singh. “The healthcare ecosystem is in dire need of change. With Inspirata, Caradigm can bring that change for providers and advance the health of the patients they serve.”

Caradigm provides an open and a flexible platform that builds a data foundation to meet the evolving demands of a dynamic healthcare environment. Caradigm Intelligence Platform aggregates data across clinical, social, operational and financial sources from disparate source systems – electronic health records, billing systems, payers, claims, pharmacy systems, labs and HIEs, coupled with the need for timely information at the point of care to address a longstanding challenge for healthcare organizations. Caradigm also provides a suite of applications for improving the patient experience of care, improving the health of populations and reducing the per capita cost of healthcare. Caradigm population health solutions enable providers to deliver the appropriate care to patients through effective coordination and patient engagement, improving outcomes and financial results.

About Inspirata, Inc.

Inspirata®, Inc. provides oncology diagnostics workflow solutions that span digital pathology; diagnostic and predictive assays; and precision medicine. It also offers cancer informatics workflows that, in combination with its natural language processing and artificial intelligence algorithms structures unstructured case files and clinician notes to provide key insights for clinical and operational activities as well as cancer reporting. Inspirata’s flagship solution is its Cancer Information Data Trust (CIDT) that generates a longitudinal view of oncology patients—from diagnosis, through treatments and therapies, to outcomes. The CIDT has extensive applications in clinical decision support, research, education, drug discovery and clinical trials enrollment. Its use will extend to physicians, patients, researchers, pharma and others. For more information, please visit www.inspirata.com or contact info@inspirata.com.

About Caradigm

Until its acquisition by Inspirata today, Caradigm was a GE Healthcare Company offering intelligent healthcare analytics and population health management solutions. Caradigm is dedicated to improving patient care, advancing the health of populations and reducing healthcare costs. Its enterprise software portfolio encompasses all capabilities critical to delivering effective population health management, including data control; healthcare analytics; and care coordination and engagement. Caradigm’s customers include large integrated delivery networks, accountable care organizations, clinically integrated networks, academic medical centers, and community hospital networks. Based in Redmond, WA, Caradigm received the Frost & Sullivan 2017 North American Health IT Value-Based Care Management Product Leadership Award. For more information, visit our website.

June 13, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

The SSI Group Announces Acquisition of ICA

Combination of administrative, financial, and clinical information exchange services enhances ability to meet the evolving needs of the healthcare industry

MOBILE, ALMarch 1, 2018The SSI Group, an industry leader in revenue cycle management (RCM) solutions, has announced the acquisition of Informatics Corporation of America (ICA), a leader in the aggregation and exchange of patient clinical data under the brand name of CareAlign.

The combined expertise and information services will help a diverse set of healthcare organizations improve their ability to address the growing need to combine administrative, financial, and clinical data driven by changes in healthcare delivery and payment models. SSI will continue to support the needs of HIEs and other healthcare organizations that need to aggregate and exchange patient clinical data through the CareAlign suite of products. Additionally, SSI will create new solutions derived from the integration of their administrative and clinical data services.

“The integration of the CareAlign solutions into the SSI services platform will provide SSI the ability to expand the breadth of health information exchange services offered to our clients,” said Jimmy Lyons, CEO and President of SSI. “SSI has 30 years of experience in the development and delivery of EDI clearinghouse services to support the information exchange requirements of our revenue cycle clients. The expertise gathered from the operations of this network, which connects thousands of providers and payers daily, can be leveraged to address the growing demand for clinical data exchange.”

Jeff Miller, Chief Product Officer at SSI adds, ”Integrating clinical information with the administrative and financial data used by SSI revenue cycle solutions will be critical in responding to the changes in payment models represented by value-based reimbursement programs like MACRA.” As these models evolve, healthcare business leaders will demand solutions that can provide a more holistic view of the operational aspects impacting revenue performance.

Ben Rooks, Managing Principal of ST Advisors observed, “SSI’s been a client since 2017 and we have discussed how to grow its breadth of services. Health networks sponsored by HIEs, provider communities, and health plans can meaningfully improve patient care while lowering the costs to deliver it. This expansion into clinical data will provide SSI clients with a complete view of their patients, marrying the clinical and financial.”

ICA was headquartered in Nashville, TN, and SSI has decided to keep the office and establish a local presence. “With the concentration of healthcare in the Nashville area, it was always in our plans to open a regional office there. We look forward to growing the office and establishing a presence in Nashville,” added Mr. Lyons.

SSI will be attending the HIMSS18 annual conference, March 5-9 in Las Vegas, Nevada, at booth #1929. For more information about SSI, visit www.thessigroup.com.

About SSI:

SSI delivers solutions that increase the accuracy and velocity of data exchange among healthcare providers and payers, with the highest levels of security. A privately held company since its founding 30 years ago, SSI is singularly focused on the healthcare industry. SSI’s commitment to our clients’ success is evident with nearly 50% of our clients relying on SSI solutions for 10 years or more. Our revenue cycle, EDI gateway, and clinical data interoperability solutions are among the best in the industry and help our clients effectively and efficiently manage their clinical and claims data. Learn how we can help you at www.thessigroup.com.

March 1, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Prognos, Healthcare AI Company, Raises $20.5 Million Towards Predicting Disease the Earliest

Cigna, GIS Strategic Ventures, Hermed, Hikma Ventures, Maywic, Merck GHI Fund, and Safeguard Scientifics bet on Prognos to revolutionize healthcare by driving earlier decisions that improve patient health and lower costs

NEW YORK, November 30, 2017 — Prognoswww.prognos.ai, an innovator in applying artificial intelligence (AI) to clinical lab diagnostics, has completed a $20.5 million Series C round of financing, bringing the company’s total funding to $42 million. The investors include CignaGIS Strategic Ventures (the venture capital arm of the Guardian Life Insurance Company), Hermed,  Hikma VenturesMaywicMerck Global Health Innovation Fund (GHI), and Safeguard Scientifics. The support validates Prognos’ leadership position in the market as the only healthcare AI company capable of delivering forward-looking and real-time insights based on laboratory and diagnostics records.

Building on Prognos’ seven-year foundation, the Series C financing will help the company meet highly targeted growth goals in the Life Sciences and Payer markets. Prognos’ solutions enable earlier identification of patients who can benefit from enhanced treatment decision-making, risk management, and quality improvement. The company is currently helping 25 Life Sciences brands to find and convert appropriate patients while building a footprint in the payer market.

“For Prognos, Series C is a focused and disciplined effort to build on our success to scale the business as we pursue our mission of predicting disease earlier to drive better outcomes for patients,” said Sundeep Bhan, Cofounder and CEO of Prognos. “We view this round as a vote of confidence from the healthcare giants and global investment firms that understand the space well and believe that Prognos can continue to lead in providing early insights to deliver better patient care and lower costs.”

The new funds will go toward expanding Prognos’ AI capabilities, new markets, and sales and marketing efforts. To date, Prognos has built the largest lab connectivity network in the U.S., processed and analyzed over 13 billion lab records for more than 180 million patients, and developed 1,000+ proprietary machine learning-enabled algorithms across 50 conditions, such as diabetes, asthma, and non-small cell lung cancer, for the lab data management and analysis. Within the last year, Prognos has also bolstered its leadership team with the additions of Chief Operating Officer Lisa Kerber, Chief Commercial Officer Stephen Silvestro and Chief Data Scientist Fernando Schwartz, Ph.D.

“The Life Sciences industry is increasingly structured around biomarkers and smaller populations where early diagnosis and treatment are key for improving outcomes,” said Joe Volpe, Managing Director, Merck GHI Fund. “Healthcare AI and the right kind of big data, such as lab and diagnostics data driving clinical decision-making, can enable us to predict which patients will benefit from a particular therapy. This round continues our investment into Prognos, the AI company that has demonstrated its capability to transform how the Life Sciences industry does business, now and in the future.”

Global health service company Cigna has been working with Prognos to use lab data and analytics to improve health engagement among its Individual and Family Plan customers.

“AI is a game changer in healthcare risk management,” said Craig Cimini, VP Strategy and Business Development at Cigna. “We have seen Prognos’ capabilities first-hand and believe health plans will greatly benefit from integrating real-time lab and diagnostics data intelligence to refine their approaches to risk adjustment, clinical quality, and care management.”

About Prognos

Prognos is a healthcare AI company focused on predicting disease to drive decisions earlier in healthcare in collaboration with payers, Life Sciences and diagnostics companies. The Prognos Registry is the largest source of clinical diagnostics information in 50 disease areas, with over 13B medical records for 180M patients. Prognos has 1000 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management and quality improvement. The company is supported by a $42M investment from Safeguard Scientifics, Inc. (NYSE: SFE), Merck Global Health Innovation Fund (GHIF), Cigna (CI), GIS Strategic Ventures, Hikma Ventures, Hermed Capital, and Maywic Select Investments. For more information, visit www.prognos.ai.

November 30, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Arcadia Healthcare Solutions Announces $30MM New Investment

Merck Global Health Innovation partners with GE Ventures and existing investors to scale leading healthcare data and advanced analytics company

BURLINGTON, Mass.– Arcadia Healthcare Solutions (“Arcadia” or the “Company”) announced today that the Merck Global Health Innovation Fund (“Merck GHI”), GE Ventures, and existing investors Peloton EquityZaffre Investments, and Morgan Stanley Alternative Investment Partners have invested $30 million of growth capital in the Company.

With over 60 enterprise customers, Arcadia is a leading healthcare data aggregation and analytics technology company with a focus on serving ambulatory networks affiliated with large payer and provider organizations, including health plans, accountable care organizations, integrated delivery networks, and large independent physician groups, among others.

Arcadia’s technology and services enable its customers to successfully drive value-based performance management programs as American healthcare shifts to a new paradigm. Arcadia is led by chief executive officer Sean Carroll, a longtime executive with over 25 years of experience in the health IT industry.

“Having Merck GHI and GE Ventures join existing investors in this round of growth capital is the optimal outcome for us,” said Carroll. “The rigorous process expands our team of blue chip investors who actively support their companies’ growth plans.”

“Arcadia fits perfectly with our initiatives supporting the transition to value based care. Arcadia’s deep expertise in transforming isolated data into critical insights that enable providers to close gaps in care and enable better outcomes is central to our investment hypothesis around Population Health,” stated Joel Krikston, Managing Director at Merck’s Global Health Innovation Fund.

“GE Ventures is excited to back Arcadia in becoming an industry leader to help payers and providers apply advanced analytics to their business models. We’re especially proud to invest in this highly experienced Boston-based team, which is now home to GE’s headquarters,” said Noah Lewis, Managing Director of healthcare at GE Ventures.

The investment allows the company to accelerate its robust product development plans in the core Arcadia Analytics platform and expand population health management market activities across the country. While the company will continue to focus on organic growth, Arcadia has made two successful acquisitions since its founding—Concordant, an EHR support services company in 2011 and Sage Technologies, a managed care services company in 2015.

“Our transformation from a proven consulting firm to a recognized, technology-led population health analytics company is complete as noted by industry experts such as KLAS ResearchGartner, and Chilmark Research,” said Carroll. “We see a bright future for our customers, investors, and team members.”

The capital raise process was managed by Robert W. Baird and supported by counsel Goodwin Proctor.

###

About Merck Global Health Innovation Fund

Merck Global Health Innovation (GHI) Fund (www.merck.com/ghi) invests in emerging companies that deliver breakthrough healthcare solutions which advance Merck’s mission to discover, develop, and provide innovative products and services that save and improve lives. Established in 2010, the GHI Fund deploys its evergreen $500 million fund to rapidly identify and develop transformative global health care opportunities. GHI is focused on identifying opportunities that are adjacent to Merck’s core business of pharmaceuticals and vaccines.

About GE Ventures

GE Ventures (www.geventures.com) is committed to identifying, scaling, and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy, and healthcare, GE Ventures helps entrepreneurs and start-ups succeed by providing access to GE’s technical expertise, capital, and opportunities for commercialization through GE’s global network of business, customers, and partners. GE Ventures offers an unparalleled level of resources through its Global Research Center, including: 35,000 engineers; 5,000 research scientists; 8,000 software professionals; as well as 40,000 sales, marketing, and development resources in over 100 countries.

About Peloton Equity

Peloton Equity, LLC (http://www.pelotonequity.com) is a newly-formed private equity firm that focuses exclusively on growth capital investments in the lower middle market of the healthcare industry. Peloton’s portfolio includes HealthPlanOne, a leading technology-enabled digital marketing firm specializing in Medicare and individual and family health insurance sales and distribution. Peloton leverages its extensive healthcare network, value-building diligence and investment process, and portfolio management playbook to add value to its portfolio companies. Peloton seeks companies with between $20 and $200 million of revenue and the management team, market opportunity and business model to grow revenues meaningfully over the life of its investment.

About Zaffre Investments

Zaffre Investments, LLC (http://www.zaffreinvestments.com/) is a wholly-owned subsidiary of Blue Cross Blue Shield of Massachusetts that is committed to adding value through investments in new products, services and technologies that aim to improve the way healthcare is delivered and received. Zaffre focuses on companies across the healthcare landscape, with a primary focus on ACOs, consumer solutions, health information technology, and behavioral health. The firm is stage agnostic, considering a company’s financial and market positions, capabilities, and core values, as well as their missions and visions for the future. Zaffre employs a true partnership model for its portfolio companies, providing strategic direction, business support, industry connections and more.

About Morgan Stanley Alternative Investment Partners

Morgan Stanley Alternative Investment Partners (http://www.morganstanleyaip.com), part of Morgan Stanley Investment Management, specializes in assisting institutional and high net worth investors achieve their goals through the design and management of alternative investment programs. Established in 2000, Morgan Stanley AIP currently has approximately $36.4 billion in assets under management and advisement.

About Arcadia Healthcare Solutions

Arcadia Healthcare Solutions (http://www.arcadiasolutions.com) is an EHR data aggregation and analytics technology company supporting ambulatory networks taking on risk and transitioning to value- based care. Arcadia specializes in integration of data from over 30 EHR vendors, enriching it with claims and operational data, and using that data to drive improvements in patient care quality, practice efficiency, and financial performance. Trusted by independent provider groups, health plans, and integrated delivery networks nationwide, with expertise in both fee-for-service optimization and value- based performance environments, Arcadia supports providers with the benchmark data, insights, and outsourced services to excel in the evolving landscape of American healthcare. Founded in 2002, Arcadia is headquartered outside Boston in Burlington, MA, with offices in Seattle, Pittsburgh, and outside Chicago in Rockford, IL.

January 6, 2017 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Vital Enters into an Agreement to Acquire Innovative Healthcare Informatics Company, Karos Health

MINNEAPOLIS, Nov. 01, 2016 (GLOBE NEWSWIRE) — Vital Images, Inc. (Vital), a Minneapolis-based enterprise medical imaging and informatics company, has entered into an agreement to acquire Karos Health (Karos), an innovative global healthcare informatics company.

The acquisition will allow Vital and Karos to offer customers and OEM partners a robust imaging and informatics solution-set. The combined technologies provide a customer-centric, modular platform that allows hospital systems to solve a broad set of enterprise imaging challenges without requiring large-scale, disruptive PACS replacement of existing systems. The combined organizations will build on Karos’ vast experience in enabling healthcare interoperability, while Vital will continue its market leadership in advanced visualization, diagnostic viewing and image-processing algorithms to support personalized medicine.

“Karos Health’s solution-set enables collaboration between healthcare providers and patient engagement, while providing secure access to complete the patient’s health record – anytime, anywhere,” says Jim Litterer, president and CEO of Vital Images. “Karos’ technology allows Vital to provide one modular solution, giving CIOs globally the ability to adapt and grow their service delivery without disrupting existing investments.”

The non-disruptive approach championed by both Vital and Karos enables hospital systems to optimize diagnostic imaging workflows and deliver enterprise-wide imaging information to the EMR, helping to improve both patient and business outcomes.

Rick Stroobosscher, CEO of Karos Health, adds “From a marketplace perspective, this transaction will deliver a comprehensive solution to help hospital systems confidently navigate the global move towards personalized medicine, population health and the requirements of value-based care.”

Statement from Jim Litterer, president and CEO of Vital
https://youtu.be/HFH2VTZ1Sag

Statement from Paul Markham, VP Marketing at Vital
https://youtu.be/X4Jd9usoU-8

About Karos Health
Karos Health is focused on elevating the quality of patient care by enabling the sharing and storing of clinical information. Karos’ Rialto platform empowers healthcare enterprises to enable cross-community access to information, facilitating collaboration between healthcare providers and patients. Karos’ EasyViz is a breakthrough product for image display, delivering diagnostic quality imaging information when and where needed. Rialto and EasyViz are based on open standards that ensure safe and secure handling of patient health information and is backed by a team with decades of experience in healthcare interoperability. For more information about Karos, visit www.karoshealth.com.

About Vital Images, Inc.
Vital Images, Inc., a Toshiba Medical Systems Group company, is a leading provider of diagnostic imaging and enterprise informatics solutions to help healthcare organizations deliver exceptional care while optimizing resources across multi-facility organizations. The company’s solutions are scalable to meet the unique needs of hospitals and imaging centers and are accessible throughout the enterprise anytime, anywhere. For more information, visitwww.vitalimages.com or join the conversation on Twitter, LinkedIn and YouTube.

November 3, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Logicalis Global Survey: Digital Brings Fresh Challenges for Three-Fourths of CIOs

Solution Provider Says Distributed IT, Shadow IT Departments, and Data Security Risks Are Top of Mind for IT Leaders as Businesses Respond to Threats from Digital Disrupters Worldwide

NEW YORK, October 24, 2016 – A new study by Logicalis, an international IT solutions and managed services provider (www.us.logicalis.com), examined the significant challenges facing CIOs worldwide as they enable businesses in every market segment to respond to threats posed by digital disrupters like Uber and Airbnb.  The 2016 Logicalis Global CIO Survey, now in its fourth year, polled over 700 CIOs worldwide. According to the survey, distributed IT, shadow IT departments and data security are among the biggest issues facing CIOs today. Download a copy of the report, “Digital Enablers: The Challenges Facing CIOs in an Age of Digital Transformation,” here: http://ow.ly/sRjQ305o2f1.

The Logicalis study also revealed that the pace of digital transformation is gathering speed with 73 percent of firms around the world, to some extent, now calling themselves “digitally enabled.” Overall, the survey showed that digital adoption conforms to an innovation bell curve in which:

  • Digitally enabled innovators, or digital disrupters, now account for 7 percent of businesses.
  • Early adopters comprise 22 percent of businesses worldwide.
  • An early majority accounts for 45 percent of firms, while 22 percent fall into the late majority category.
  • And laggards, or those not digitally enabled at all, account for just 5 percent of businesses around the globe.

“This speaks both to the huge benefits that digital transformation brings,” says Mark Rogers, Chief Executive Officer, Logicalis Group, “but also to the scale of the challenge posed by digital disrupters and early transformers – while such a rapid transformation almost certainly means big changes for CIOs and IT departments.”

Big Challenges for CIOs

This rapidly changing environment does indeed pose big challenges for CIOs, the survey found.  CIOs have, for instance, less control over IT spending than ever before – 40 percent of CIOs now say they make 50 percent or fewer of their companies’ IT spending decisions.

This trend is also reflected in the frequency with which CIOs are bypassed altogether – with line of business buying technology without involving IT at all.  The proportion reporting that this happens often, very often or most of the time has risen from 29 percent in 2015 to 39 percent in 2016.

Distributed IT and the Shadow IT Department

One result of this loss of control is a move away from centralized IT, with more and more CIOs now operating in “distributed” IT environments.  Perhaps surprisingly, this decentralization of IT, which is a natural extension of “shadow IT,” is no longer seen as subversive, however, and is instead viewed as a positive and essential element of digital transformation.

For example, though the vast majority of CIOs (83 percent) report that line of business departments now employ IT people whose role is to support business function-specific software, applications and cloud services – essentially acting as shadow IT departments – CIOs seem content to work with them.  In fact, more than one-fifth of the world’s IT leaders (22 percent) report working with these “shadow IT departments” on a daily basis, while 41 percent report doing so at least weekly.

“The challenge for IT departments and CIOs is to find ways to support these specialists effectively,” says Vince DeLuca, Chief Executive Officer, Logicalis US, “securing the infrastructure, applications and vital data without stifling the ‘shadow innovation’ their skills support.”

Security Challenges

Together, the combination of the Internet of Things (IoT), distributed IT, and the increased pervasiveness of applications into the very core of the business – along with an ever-evolving threat landscape – represents a perfect security storm.

As a result, the CIOs surveyed cited security as far and away the biggest challenge related to the increased use of cloud services.  More than three quarters (78 percent) pointed to security as a challenge, with related issues like data sovereignty (47 percent) and local data regulations (37 percent) coming in second and third.

Looking at security threats in more detail, CIOs expect the prevalence of increasingly sophisticated threats (61 percent) to be the No. 1 issue for the next 12 months, while issues like ransomware and corporate extortion were highlighted by more than half (56 percent).

Looking Outside for Help

The sheer range of issues facing CIOs as a result of their organizations’ digital transformation means the pressure to hand off day-to-day technology management, to focus on strategy, and to reframe IT departments as internal service providers is now greater than ever.

In response, CIOs are increasingly seeking partner-led and partner-delivered services.  This year, one-fourth (24 percent) of the CIOs surveyed say they outsource most (more than 50 percent) of their IT, while the number outsourcing none or just 10 percent of their IT has dropped dramatically – falling respectively to 9 percent (compared to 13 percent in 2015) and 19 percent (compared to 26 percent in 2015).

“As digital innovation accelerates, the winners will create new customer experiences, make faster and better decisions through smarter collaboration, and create new digital business models and revenue streams securely,” Rogers says. “CIOs and IT leaders can play a leading role in enabling that innovation, drawing on skills from insightful partners to help shape their businesses and lead their sectors through the application of digital technologies.  I am delighted that Logicalis is already helping clients to plan their digital journeys, releasing the creativity that runs through their workforces and using digital technology to deliver outstanding results.”

About Logicalis

Logicalis is an international multi-skilled solution provider providing digital enablement services to help customers harness digital technology and innovative services to deliver powerful business outcomes.

Our customers cross industries and geographical regions; our focus is to engage in the dynamics of our customers’ vertical markets including financial services, TMT (telecommunications, media and technology), education, healthcare, retail, government, manufacturing and professional services, and to apply the skills of our 4,000 employees in modernizing key digital pillars, data center and cloud services, security and network infrastructure, workspace communications and collaboration, data and information strategies, and IT operation modernization.

We are the advocates for our customers for some of the world’s leading technology companies including Cisco, HPE, IBM, NetApp, Microsoft, VMware and ServiceNow.

The Logicalis Group has annualized revenues of over $1.5 billion from operations in Europe, North America, Latin America and Asia Pacific. It is a division of Datatec Limited, listed on the Johannesburg Stock Exchange and the AIM market of the LSE, with revenues of over $6.5 billion.

For more information, visit www.us.logicalis.com.

October 24, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Survey: 8 in 10 Hospital Leaders Say Predictive Analytics is Important to Future Yet Only One-Third Use It

Lack of appropriate tools and trained personnel ranked as top barriers to adoption

SALT LAKE CITY – Sept. 7, 2016 – Nearly 80 percent of hospital executives believe the future of healthcare could be significantly improved through the use of predictive analytics, a population health management tool that can help providers stay one step ahead of costly problems like preventable readmissions, patient downturns and contracts with insurers that pay less than the cost of providing care. Yet only 31 percent of hospitals have used the technology for more than a year, and 19 percent have no plans to do so.

Those results from an August survey of 136 hospital and health system executives by Health Catalyst point to potentially significant barriers to the adoption of predictive analytics. They may also signal pent up demand for the advanced form of analytics, which has been touted as a solution to many of healthcare’s problems and as key to the development of more effective “personalized” treatments for common diseases such as cancer.

Top barrier to adoption: “Right data or tools”

Both current users and non-users of predictive analytics agree (32%) that the top barrier to its adoption is the lack of appropriate data or tools and infrastructure, according to the survey. That result is not unexpected since producing reliable predictions of future probabilities or trends requires both an accessible and trusted source of data aggregated from multiple IT systems—electronic health records (EHR), financial systems, etc.—as well as analytic applications to drive the predictions and make them easy for front-line staff to use.

Survey respondents said the next most significant barriers to the use of predictive analytics were a lack of people or skills (26%) and a lack of executive support or budget (20%). Few seem to question the effectiveness of the technology; only one respondent said past efforts had failed to show results. And despite the relative youth of predictive analytics technology, confidence in its accuracy ranged from neutral to very strong among respondents. Only 2 percent said the technology produces inaccurate results.

Pent up demand?

Apparently driven by faith in predictive analytics’ ability to deliver meaningful results, demand for the technology appears to be strong among hospital leaders. In addition to the 31 percent of respondents who already use it, 38 percent said they plan to adopt predictive analytics within the next three years. Fourteen percent of that group said they will adopt it in the next 12 months.

Still, nearly one-third of the survey takers are on the fence. In addition to the 19 percent who said they have no plans to use predictive analytics, another 11 percent are unsure whether they will use it in the future or not.

Even among those who plan to adopt predictive analytics, few said they have the budget to allocate significant resources to the effort. Most (37%) are tip-toeing into the space with commitments or planned commitments of 1-3 people devoted to the task of leveraging analytics for predictions. Only 8 percent said they would allocate more than four people to that role.  Thirty-four percent of respondents said they were unsure how many people they would have work in the area.

Preventive care tops list of uses

Both current users of predictive analytics and prospective users agreed (58%) the top priority for its use is to alert caregivers to interventions that may prevent health declines among high-risk patients, according to the survey. Asked to name the top three priorities for the use of the technology, respondents assigned the second and third spots to predicting financial outcomes (such as patient cost or likelihood of patients to pay their bills) (52%), and improving the ability of providers to negotiate contracts with insurers (42%).

Other priorities for predictive analytics identified by survey takers were projecting patient health outcomes and satisfaction (38%) and improving the quality of diagnoses (33%). Falling last on the list of priorities was the forecasting of staffing and supply chain needs (27%).

EHR tops list of preferred data sources

When asked to list the top three sources of data for making predictions, respondents most often selected clinical data from the EHR (80%).  Tied for second as important data sources were claims data and patient outcomes data, both selected by 53 percent of respondents. Financial data was the next most selected category (50%), followed by non-medical patient demographics (22%) and patient satisfaction data (21%).

“Overall, the survey findings point to a growing need within the provider community for solutions that help to identify long-term rising-risk patients who are on their way to becoming high-cost consumers of heath care,” said Levi Thatcher, Director of Data Science at Health Catalyst. “With an ever greater light being cast on system-wide inefficiencies, providers are hungry for analytics that will help them identify and treat these patients before their health deteriorates, both improving their lives and reducing needless spending across the system.”

Methods

Survey results reflect the opinions of 136 healthcare professionals who responded to an online survey in August 2016. Respondents included 34 CEOs; 18 chief financial officers; 26 chief information and chief medical information officers; and a variety of other executive and departmental leadership roles. They work for organizations ranging from some of the nation’s largest urban academic medical centers and integrated delivery networks to small, rural critical access facilities.

About Health Catalyst

Health Catalyst is a mission-driven data warehousing, analytics and outcomes-improvement company that helps healthcare organizations of all sizes perform the clinical, financial, and operational reporting and analysis needed for population health and accountable care. Our proven enterprise data warehouse (EDW) and analytics platform helps improve quality, add efficiency and lower costs in support of more than 70 million patients for organizations ranging from the largest US health system to forward-thinking physician practices. For more information, visit https://www.healthcatalyst.com, and follow us on Twitter, LinkedIn and Facebook.       

September 7, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

JAMIA Study: Wolters Kluwer Surveillance System Reduces Sepsis Deaths

The Decision Support Software Improved Early Diagnosis Using Automated Data Analysis and Accurate Alerts Sent to Mobile Devices

May 25, 2016 – The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that The Journal of the American Medical Informatics Association (JAMIA) has published a study by researchers Sharad Manaktala, MD, PhD, et al. detailing a significant reduction in sepsis mortality using automated surveillance and real-time analysis. The study examines how clinicians at Alabama’s Huntsville Hospital decreased sepsis-related deaths by 53% during a 10-month period using a combination of clinical change management and electronic alerting from POC Advisor™, a highly-accurate clinical decision support (CDS) software. The system’s alerts detect sepsis early and guide clinicians to deliver the appropriate treatment, resulting in a breakthrough in alert accuracy, reaching 95% sensitivity and 82% specificity during the study period.

The study, “Evaluating the Impact of a Computerized Surveillance Algorithm and Decision Support System on Sepsis Mortality,” is currently available online and will appear in the June print edition of JAMIA.

Sepsis is the deadliest condition treated in hospital critical care units, claiming approximately 750,000 lives in U.S. hospitals every year. At an estimated $20 billion annually, it is also the country’s most expensive condition to treat. The risk of death increases significantly every hour sepsis goes untreated, yet early diagnosis has long been a struggle because many other acute medical conditions cause similar signs and symptoms.

Using an automated, real-time surveillance algorithm, POC Advisor aggregates, normalizes and analyzes patient data from disparate clinical systems and delivers early sepsis alerts and treatment advice to clinicians via mobile devices and portals. Hundreds of rules built into the platform account for variables specific to individual patients, including comorbidities and medication abnormalities, thereby maximizing the accuracy of alerts and advice.

“There is no single test to identify sepsis; it requires a clinical diagnosis. Delays in diagnosis are very common, resulting in delays in treatment,” said study co-author Stephen Claypool, MD. “Prior to this study, there hasn’t been a study of an electronic system that I’m aware of that has significantly improved mortality. That’s because most systems generate many false positive alerts, so they are ignored and outcomes are not improved. In this study, we used an electronic solution that takes into account existing patient co-morbidities and labs and adjusts the analysis on a patient-specific basis.

“This system is much more accurate, with a highly specific alerting system that minimizes alert fatigue,” added Dr. Claypool, Medical Director of Clinical Software Solutions at Wolters Kluwer. “In this study, Huntsville clinicians acted promptly on the alerting advice, so they were able to more effectively identify and treat sepsis well before a patient’s condition worsened. The end result was a dramatic improvement in mortality.”

The study also incorporated change management practices focused on sepsis education and process improvement for the clinical staff. The education program ensured that the nursing staff was properly trained to respond to sepsis alerts in a timely manner using the latest evidence-based practices.

“Efforts to develop similar CDS tools oftentimes fail because clinicians simply cannot trust the accuracy of the alerts. Either the system has low sensitivity and therefore does not identify all cases of sepsis, or low specificity, which leads to too many false positives resulting in ignored alerts,” said Sean Benson, Vice President and General Manager of POC Advisor at Wolters Kluwer Clinical Software Solutions. “If a tool is going to help doctors and nurses save lives, they have to trust that it works. Most CDS systems fail to achieve sensitivity and specificity levels higher than 50%. However, at the conclusion of our study, POC Advisor achieved alert sensitivity and specificity of 95% and 82%, respectively. That is unprecedented in published literature.”

The study’s publication in JAMIA follows the release of new definitions and clinical criteria for sepsis (Sepsis-3) from the Third International Consensus Definitions Task Force earlier this year. Dr. Claypool noted that while it more accurately defines the condition, Sepsis-3 does little to address the need for improved care.

“Currently, there is no medical evidence to suggest that the Sepsis-3 criteria will detect sepsis earlier than previous methods and in fact may lead to longer delays,” he said. “The reduction in sepsis mortality at Huntsville is a result of effective early alerts that allowed clinicians to treat the patients long before they suffered life-threatening organ dysfunction.”

Follow POC Advisor on Twitter.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visithttp://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

May 26, 2016 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.